Tim Kaine actually said...
While drug pricing is outside of the FDA's jurisdiction and the most robust solutions likely involve HHS and CMS, this is something this committee needs to address this Congress.
Context
Kaine calls for congressional action on drug pricing despite FDA's limited role.
04/03/2017